Evaluation of immunogenicity and tolerability of a live attenuated hepatitis A vaccine in Indian children

Indian Pediatrics

Volumn 43, Issue 11, 2006, Pages 983-987

  Bhave, Sheila ^a   Bavdekar, Ashish ^a   Madan, Zinobia ^b   Jha, Rasendrakumar ^b   Bhure, Shraddha ^b   Chaudhari, Jayant ^a   Pandit, Anand ^a  

^a KEM HOSPITAL   (India)

^b WOCKHARDT LIMITED   (India)

Author keywords

Immunogenicity; Live attenuated hepatitis A vaccine; Tolerability

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN G ANTIBODY; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G; LIVE VACCINE;

ANTIBODY PRODUCING CELL; ARTICLE; BLOOD EXAMINATION; CHILD; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; HEPATITIS A; HUMAN; IMMUNOGENICITY; INDIA; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; SINGLE DRUG DOSE; BLOOD; CLINICAL TRIAL; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; SAFETY;

CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS A VACCINES; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOGLOBULIN G; INDIA; INFANT; MALE; SAFETY; VACCINES, ATTENUATED;

EID: 33947132250     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hepatitis A vaccines: WHO position paper. Weekly Epidemiological Record, 2000;75: 38-42.
2. Arankalle VA. Hepatitis A vaccine strategies and their relevance in the present scenario. Indian J Med Res 2004;119: 3-6.
3. Mall ML, Rai RR, Philip M, Naik G, Parekh P, Bhawnani SC, et al. Seroepidemiology of hepatitis A in India: changing pattern. Indian J Gastroenterol, 2001; 20: 132-135.
4. Halliday ML, Kang LY, Zhou TK, Hu MD, Pan QC, Fu TY, et al. An epidemic of hepatitis A attributable to the ingestion of raw clams in Shanghai, China. J Infect Dis 1991;164: 852-859.
5. Sebastian B, Mathai S, Mathew G, Ouseph M, Balakrishnan. An outbreak of hepatitis A in central Kerala-clinical profile. Abstract Indian J Gastroenterol, 1998; 17: S10.
6. Zhuang F, Jiang Q, Gong Y, Mo S, Qi Y, Quian W, et al. Epidemiological effects of live attenuated hepatitis A vaccine (H2 strain): results of A 10-year observation. Zhonghua Liu Xing Bing Xue Za Zhi. 2001; 22: 188-190 (Article in Chinese).
7. Dagan R, Leventhal A, Anis E, Slatter P, Ashur Y, Shouval D. Incidence of Hepatitis A in Israel following universal immunization of toddlers. JAMA 2005; 294: 202-210.
8. Wasley A, Samandari T, Bell BP. Incidence of Hepatitis A in the United States in the era of vaccination. JAMA 2005; 294: 194-201.
9. John T J. Principles and Practice of Immunization In: IAP Textbook of Pediatrics, 3rd edn. A. Parthasarthy, ed. New Delhi: Jaypee Brothers Medical Publishers P (Ltd.), 2006; 193-197.
10. Van Herck K, Van Damme P. Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence J Med Virol. 2001; 63: 1-7.
11. Mao JS, Chai SA, Xie RY, Chen NL, Jiang Q, Zhu XZ, et al. Further evaluation of safety and protective efficacy of live attenuated hepatitis A vaccine (H2 strain) in humans. Vaccine 1997; 15: 944-946.
12. Mao JS, Xie RY, Huang HY, Chai SA, Chen NL, Yu PH, et al. Studies in monkeys of attenuated hepatitis A variants. Scientia Sinica 1988; 31: 338-343.
13. Xu Z, Wang X, Li R, Meng Z, Zhang Y, Gong J, et al. Immunogenicity and efficacy of two live attenuated hepatitis A vaccines (H 2 strains and LA-1 strains) Zhonghua Yi Zue Za Zhi. 2002; 82: 678-681.
14. Zhuang F, Qian W, Mao Z, Gong Y, Jiang Q, Jiang L, et al. Persistent efficacy of live attenuated hepatitis A vaccine (H2 strain) after a mass vaccination program. Chin Med J 2005; 118: 1851-1856.
15. Wang X, Meng Z, Li R. Comparison of immunology effects between live attenuated hepatitis A vaccine and inactivated hepatitis A vaccine. Zhonghua Yi Xue Za Zhi, 2000; 80: 422-424.